Cellular chemokine CCL18 increases matrix metalloproteinases expression and promotes ovarian cancer cell invasion and metastasis in vivo

被引:0
|
作者
Yan Feng [1 ]
Qiaoyun Yin [1 ]
Hongjing Yu [1 ]
Lijun Shi [2 ]
Qi Wang [1 ]
机构
[1] Research Department,Affiliated Tumor Hospital of Guangxi Medical University
[2] Chemotherapy Center,The First Affiliated Hospital of Guangxi Medical
关键词
chemokine; CCL18; ovarian cancer; xenografts; matrix metalloproteinases;
D O I
10.16190/j.cnki.45-1211/r.2018.09.001
中图分类号
R737.31 [卵巢肿瘤];
学科分类号
摘要
Objective:To study the effect of cell chemokine(CC motif)ligand 18(CCL18)on ovarian cancer proliferation and metastasis.Methods:This study first analyzed the effects of overexpression of CCL18 on the growth in a subcutaneous ovarian cancer xenografts mouse model.Real-time quantitative PCR was used to detect the expression of matrix metalloproteinases(MMPs)in xenografts tissues.Then,an ovarian cancer orthotropic xenografts model was used to access the effect of CCL18 on ovarian cancer metastasis.Results:Over expressing CCL18 in SKOV3 cells did not significantly promote the tumor growth of subcutaneous xenografts.But the mRNA levels of MMP1,MMP7,MMP11 and MMP15 were significantly increased(P <0.05).The mRNA level of MMP12 was not changed(P >0.05).In orthotopic xenografts ovarian cancer mouse model,metastasis appeared in more organs in CCL 18 overexpressed SKOV3 cells than GFP/SKOV3 cells.Conclusion:CCL18 increased the expression of MMPs in ovarian cancer cells and promoted metastasis of ovarian cancer cells in vivo.
引用
收藏
页码:1185 / 1190
页数:6
相关论文
共 10 条
  • [1] siRNA沉默CCL18的表达抑制卵巢上皮癌SKOV3细胞的侵袭和迁移
    张玮
    杨莹珠
    李力
    王琪
    [J]. 中国肿瘤生物治疗杂志, 2013, 20 (01) : 30 - 36
  • [2] CCL18 From Tumor-Cells Promotes Epithelial Ovarian Cancer Metastasis via mTOR Signaling Pathway
    Wang, Qi
    Tang, Yong
    Yu, Hongjing
    Yin, Qiaoyun
    Li, Mengdi
    Shi, Lijun
    Zhang, Wei
    Li, Danrong
    Li, Li
    [J]. MOLECULAR CARCINOGENESIS, 2016, 55 (11) : 1688 - 1699
  • [3] Ovarian cancer: diagnostic, biological and prognostic aspects[J] . Ben Davidson,Claes G Trop&eacute.Womens Health . 2014 (5)
  • [4] Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research[J] . Kipps Emma,Tan David S P,Kaye Stan B.Nature reviews. Cancer . 2013 (4)
  • [5] Triptolide inhibits ovarian cancer cell invasion by repression of matrix metalloproteinase 7 and 19 and upregulation of E-cadherin
    Zhao, Hongxi
    Yang, Zhifu
    Wang, Xiaohong
    Zhang, Xianzhi
    Wang, Meng
    Wang, Yukun
    Mei, Qibing
    Wang, Zhipeng
    [J]. EXPERIMENTAL AND MOLECULAR MEDICINE, 2012, 44 (11): : 633 - 641
  • [6] Multiple steps of HLA-G in ovarian carcinoma metastasis: Alter NK cytotoxicity and induce matrix metalloproteinase-15 (MMP-15) expression[J] . Aifen Lin,Hui-Hui Xu,Dan-Ping Xu,Xia Zhang,Qing Wang,Wei-Hua Ya.Human Immunology . 2012
  • [7] Mesothelin enhances invasion of ovarian cancer by inducing MMP-7 through MAPK/ERK and JNK pathways[J] . Chang Ming-Cheng,Chen Chi-An,Chen Pao-Jen,Chiang Ying-Cheng,Chen Yu-Li,Mao Tsui-Lien,Lin Han-Wei,Lin Chiang Wen-Hsien,Cheng Wen-Fang.The Biochemical journal . 2012 (2)
  • [8] CCL18 from Tumor-Associated Macrophages Promotes Breast Cancer Metastasis via PITPNM3
    Chen, Jingqi
    Yao, Yandan
    Gong, Chang
    Yu, Fengyan
    Su, Shicheng
    Chen, Jianing
    Liu, Bodu
    Deng, Hui
    Wang, Fengsong
    Lin, Ling
    Yao, Herui
    Su, Fengxi
    Anderson, Karen S.
    Liu, Qiang
    Ewen, Mark E.
    Yao, Xuebiao
    Song, Erwei
    [J]. CANCER CELL, 2011, 19 (04) : 541 - 555
  • [9] First-line systemic treatment of ovarian cancer: a critical review of available evidence and expectations for future directions[J] . Current Opinion in Oncology . 2010 (5)
  • [10] The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis[J] . Chieh Chang,Zena Werb.Trends in Cell Biology . 2001 (11)